Baseline data on long-duration type 1 diabetic patients who died or survived during a 7-year follow-up
| . | Dead . | Alive . | P . |
|---|---|---|---|
| n | 27 | 108 | |
| Age (years) | 59.6 ± 12.8 | 56.4 ± 10.5 | 0.23 |
| Men:women | 17:10 | 71:37 | 0.78 |
| Duration of diabetes (years) | 39.1 ± 6.8 | 37.7 ± 6.8 | 0.35 |
| BMI (kg/m2) | 25.4 ± 3.5 | 26.2 ± 3.4 | 0.32 |
| Systolic blood pressure (mmHg) | 148 ± 22 | 143 ± 21 | 0.25 |
| Diastolic blood pressure (mmHg) | 77 ± 12 | 77 ± 9 | 0.99 |
| HbAIc (%) | 7.2 ± 2 | 6.9 ± 1.3 | 0.4 |
| Serum creatinine (μmol/l) | 124 ± 78 | 91 ± 27 | 0.041 |
| Total cholesterol (mmol/l) | 5.7 ± 1.2 | 5.5 ± 1.1 | 0.36 |
| Triglycerides (mmol/l) | 1.5 (0.4–4.3) | 1.1 (0.3–8.2) | 0.07 |
| Abnormal albumin excretion (%) | 59 | 18.5 | <0.001 |
| Smoking (%) | 56 | 43 | 0.22 |
| Preexisting cardiovascular disease (%) | 67 | 39 | 0.009 |
| Use of antihypertensive medication | 12 (44) | 28 (26) | 0.06 |
| Use of ACE inhibitors | 6 (22) | 16 (15) | 0.35 |
| . | Dead . | Alive . | P . |
|---|---|---|---|
| n | 27 | 108 | |
| Age (years) | 59.6 ± 12.8 | 56.4 ± 10.5 | 0.23 |
| Men:women | 17:10 | 71:37 | 0.78 |
| Duration of diabetes (years) | 39.1 ± 6.8 | 37.7 ± 6.8 | 0.35 |
| BMI (kg/m2) | 25.4 ± 3.5 | 26.2 ± 3.4 | 0.32 |
| Systolic blood pressure (mmHg) | 148 ± 22 | 143 ± 21 | 0.25 |
| Diastolic blood pressure (mmHg) | 77 ± 12 | 77 ± 9 | 0.99 |
| HbAIc (%) | 7.2 ± 2 | 6.9 ± 1.3 | 0.4 |
| Serum creatinine (μmol/l) | 124 ± 78 | 91 ± 27 | 0.041 |
| Total cholesterol (mmol/l) | 5.7 ± 1.2 | 5.5 ± 1.1 | 0.36 |
| Triglycerides (mmol/l) | 1.5 (0.4–4.3) | 1.1 (0.3–8.2) | 0.07 |
| Abnormal albumin excretion (%) | 59 | 18.5 | <0.001 |
| Smoking (%) | 56 | 43 | 0.22 |
| Preexisting cardiovascular disease (%) | 67 | 39 | 0.009 |
| Use of antihypertensive medication | 12 (44) | 28 (26) | 0.06 |
| Use of ACE inhibitors | 6 (22) | 16 (15) | 0.35 |
Data are means ± SD, median (range), or n (%). Student’s t test or χ2 test used as appropriate. Serum triglycerides analyzed by Mann-Whitney U test.